Catalyst Wire Dossier Catalyst Wire Dossier

LEVETIRACETAM ORAL

levetiracetam · Camber Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEVETIRACETAM ORAL, covering 2013-02-28 to 2013-02-28. Get the full timeline:

Most recent: FDA Approved: LEVETIRACETAM — Original Application (Camber Pharmaceuticals, Inc.)

See pricing